Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for MannKind Corp [MNKD]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 9.04%
SELL
25.00%
return 0.87%
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

3.78% $ 4.67

SELL 154462 min ago

@ $3.58

Issued: 14 Feb 2024 @ 14:32

Return: 30.63%

Previous signal: Feb 14 - 13:57

Previous signal: Buy

Return: 1.56 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Profile picture for MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States...

Stats
Today's Volume 2.39M
Average Volume 2.78M
Market Cap 1.27B
EPS $0 ( 2024-05-14 )
Next earnings date ( $0.0100 ) 2024-08-05
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 116.75
ATR14 $0.00800 (0.17%)
Insider Trading
Date Person Action Amount type
2024-05-24 Blank Burkhard Sell 16 151 Common Stock, $0.01 Par Value
2024-05-17 Thomson David Buy 77 420 Common Stock, $0.01 Par Value
2024-05-17 Thomson David Sell 85 797 Common Stock, $0.01 Par Value
2024-05-18 Thomson David Sell 6 916 Common Stock, $0.01 Par Value
2024-05-21 Thomson David Sell 23 537 Common Stock, $0.01 Par Value
INSIDER POWER
60.77
Last 99 transactions
Buy: 6 197 871 | Sell: 1 623 400

Volume Correlation

Long: 0.13 (neutral)
Short: 0.68 (moderate)
Signal:(68.634) Neutral

MannKind Corp Correlation

10 Most Positive Correlations
SOUN0.916
RCM0.913
ICLR0.904
AIHS0.889
BCYC0.884
HALO0.883
ERIE0.882
VEON0.881
OSS0.878
STRL0.878
10 Most Negative Correlations
SABR-0.89
MFIN-0.883
RAPT-0.877
DPRO-0.86
SOFO-0.853
SSP-0.85
FIVN-0.844
CYAN-0.842
DBX-0.838
SMSI-0.834

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MannKind Corp Correlation - Currency/Commodity

The country flag 0.23
( neutral )
The country flag 0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.05
( neutral )
The country flag 0.29
( neutral )

MannKind Corp Financials

Annual 2023
Revenue: $198.96M
Gross Profit: $136.19M (68.45 %)
EPS: $-0.0447
FY 2023
Revenue: $198.96M
Gross Profit: $136.19M (68.45 %)
EPS: $-0.0447
FY 2022
Revenue: $99.77M
Gross Profit: $42.27M (42.37 %)
EPS: $-0.440
FY 2021
Revenue: $75.44M
Gross Profit: $36.59M (48.49 %)
EPS: $-0.320

Financial Reports:

No articles found.

MannKind Corp Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5587511062622 seconds
Number of API calls: 2
Number of DB calls: 8